The fibroblast growth factor receptor 4 (FGFR4) alterations play an essential role in developing cancer in the breast, ovarian, prostate, colon, rhabdomyosarcoma, pancreatic, and gastric, hepatocellular, and pituitary adenocarcinomas. The gene discussed is FGFR4; the disease is cancer.